A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

Clinical trial NCT05038618 · COMPLETED

Trial details

NCT number: NCT05038618
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-08-02
Primary completion: 2021-10-14
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.